
Sign up to save your podcasts
Or


Dr. Albert Aboseif and Dr. Daniel Bireley, of Cleveland Clinic’s Mellen Center for Multiple Sclerosis, discuss postural orthostatic tachycardia syndrome (POTS), including mechanisms that might contribute to the development of POTS and current immunotherapy research.
By Cleveland Clinic Center for Continuing Education5
77 ratings
Dr. Albert Aboseif and Dr. Daniel Bireley, of Cleveland Clinic’s Mellen Center for Multiple Sclerosis, discuss postural orthostatic tachycardia syndrome (POTS), including mechanisms that might contribute to the development of POTS and current immunotherapy research.

5,016 Listeners

292 Listeners

3,331 Listeners

1,154 Listeners

3,526 Listeners

9,248 Listeners

8,947 Listeners

196 Listeners

521 Listeners

29,191 Listeners

229 Listeners

1,657 Listeners

391 Listeners

230 Listeners

26 Listeners